+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
THEMISMED

Themis Medicare Share Price

 
25.74% Fall from 52W High

 

Themis Medicare live price: ₹109.90. It opened at ₹112 vs previous close ₹112; intraday high/low: ₹115/₹109. The 50 & 200 DMA stand at ₹107.50/₹107.40.

Themis Medicare Performance

  • Today's Low
  • ₹109
  • Today's High
  • ₹115
  • 52 Week Low
  • ₹65
  • 52 Week High
  • ₹148
  • Open Price₹112
  • Previous Close₹112
  • Volume72,328
  • 50 DMA₹107.50
  • 100 DMA₹102.80
  • 200 DMA₹107.40

Themis Medicare Chart

Investment Returns

  • Over 1 Month + 8.28%
  • Over 3 Month + 29.35%
  • Over 6 Month + 20%
  • Over 1 Year -11.94%

Smart Investing Starts Here Start SIP with Themis Medicare for Steady Growth!

Invest Now

Themis Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 884.9
  • PEG Ratio
  • -9.2
  • Market Cap Cr
  • 1,012
  • P/B Ratio
  • 2.5
  • Average True Range
  • 6.5
  • EPS
  • 0.1
  • Dividend Yield
  • 0.5
  • MACD Signal
  • 2
  • RSI
  • 47.22
  • MFI
  • 80.58

Latest Stock News Updates

Themis Medicare Ltd - 530199 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Vividhmargi Investments Pvt Ltd

Themis Medicare Ltd - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please refer to the RTA Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.

Themis Medicare Ltd - 530199 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 03, 2026 for Vividhmargi Trust

Themis Medicare Financials

Themis Medicare Technicals

EMA & SMA

Current Price
₹109.90
-2.52 (-2.24%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹113.20
  • 50 Day
  • ₹107.50
  • 100 Day
  • ₹102.80
  • 200 Day
  • ₹107.40

Resistance and Support

111.43 Pivot Speed
  • R3 119.10
  • R2 117.00
  • R1 113.50
  • S1 107.80
  • S2 105.80
  • S3 102.20

Themis Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-28 Audited Results & Final Dividend
2026-02-13 Quarterly Results & issue of Warrants
2025-11-13 Quarterly Results
2025-08-01 Quarterly Results
2025-05-20 Audited Results & Final Dividend
Date Purpose Remarks
2025-09-05 FINAL Rs.0.50 per share(50%)Final Dividend
View Themis Medicare Dividend History Arrow
Date Purpose Remarks
2023-10-10 Split Stock split from Rs. 10/- to Re. 1/-.

Themis Medicare Shareholding Pattern

67.11%
32.78%
0.11%
0.01%

About Themis Medicare

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products especially in Formulation and API activity. View More
  • NSE Symbol
  • THEMISMED
  • BSE Symbol
  • 530199
  • Executive Director,Managing Director,Chief Executive Officer
  • Sachin D Patel
  • ISIN
  • INE083B01024

Similar Stocks to Themis Medicare

Themis Medicare FAQs

Themis Medicare share price is ₹109 As on 18 July, 2026 | 02:18

The Market Cap of Themis Medicare is ₹1012.2 Cr As on 18 July, 2026 | 02:18

The P/E ratio of Themis Medicare is 884.9 As on 18 July, 2026 | 02:18

The PB ratio of Themis Medicare is 2.5 As on 18 July, 2026 | 02:18

The 52 week High & Low of Themis Medicare is ₹148/₹65 respectively As on 18 July, 2026 | 02:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23